Delivery Order SPE2DB20D1051-SPE2DB25FD9BN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,198.85 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $2,496.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,515.92 to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to be performed at the vendor's Conshohocken, Pennsylvania location. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors (0.5 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a single-source procurement with no set-aside designation, issued under a competitive contracting mechanism. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9BNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,543.34 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pens (0.5 mL) on August 18, 2025, with completion scheduled for August 19, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order draws from AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, brand-name and generic drugs, and vaccines. Mounjaro is a diabetes medication that aligns with the contractor's demonstrated portfolio of therapeutic products delivered through the DLA Medical Supply Chain to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/18/25 |